BOSTON-- (BUSINESS WIRE)--Cephalogics today announced study results from a blood-phantom platform that demonstrated the accuracy and sensitivity of the company’s non-invasive, portable brain perfusion ...
Fig. 1. CBF and Tmax maps derived from the model and CTP showing three patients with different cores and low perfusion volumes in the test dataset and the corresponding maximum intensity projection ...
Investigators used MRI to evaluate brain perfusion in patients with transfusion-dependent (n=54) and non–transfusion-dependent (n=23) β-thalassemia versus 56 controls. They found that relative ...
BOSTON--(BUSINESS WIRE)--Cephalogics today announced that it was able to demonstrate repeatability of brain images in healthy subjects in their visual stimulus study. This study also showed that the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果